PA3-17

DB18569InvestigationalCell transplant therapies

PA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.

Mechanism
Curator reviewed
Also known as
Chimeric Antigen Receptor T Cells targeting CD7
Code names
PA-317

Resolves to

Targets
P09564CD7

What you can answer from here — as of July 09, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with PA3-17, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In